Fractal-Based Analysis of Bone Microstructure in Crohn's Disease: A Pilot Study.
Crohn’s disease
bone loss
bone microstructure
fractal-based analysis
glucocorticoid treatment
imaging methods
risk factors
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
20 Dec 2020
20 Dec 2020
Historique:
received:
09
11
2020
revised:
07
12
2020
accepted:
13
12
2020
entrez:
9
1
2021
pubmed:
10
1
2021
medline:
10
1
2021
Statut:
epublish
Résumé
Crohn's disease (CD) is associated with bone loss and increased fracture risk. TX-Analyzer™ is a new fractal-based technique to evaluate bone microarchitecture based on conventional radiographs. The aim of the present study was to evaluate the TX-Analyzer™ of the thoracic and lumbar spine in CD patients and healthy controls (CO) and to correlate the parameters to standard imaging techniques. 39 CD patients and 39 age- and sex-matched CO were analyzed. Demographic parameters were comparable between CD and CO. Bone structure value (BSV), bone variance value (BVV) and bone entropy value (BEV) were measured at the vertebral bodies of T7 to L4 out of lateral radiographs. Bone mineral density (BMD) and trabecular bone score (TBS) by dual energy X-ray absorptiometry (DXA) were compared to TX parameters. BSV and BVV of the thoracic spine of CD were higher compared to controls, with no difference in BEV. Patients were further divided into subgroups according to the presence of a history of glucocorticoid treatment, disease duration > 15 years and bowel resection. BEV was significantly lower in CD patients with these prevalent risk factors, with no differences in BMD at all sites. Additionally, TBS was reduced in patients with a history of glucocorticoid treatment. Despite a not severely pronounced bone loss in this population, impaired bone quality in CD patients with well-known risk factors for systemic bone loss was assessed by TX-Analyzer™.
Identifiants
pubmed: 33419268
pii: jcm9124116
doi: 10.3390/jcm9124116
pmc: PMC7766043
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Clin Med. 2019 Dec 10;8(12):
pubmed: 31835600
IEEE Trans Pattern Anal Mach Intell. 1984 Jun;6(6):661-74
pubmed: 22499648
Osteoporos Int. 2019 Jun;30(6):1145-1156
pubmed: 30805679
MD Comput. 1997 Jul-Aug;14(4):306-17
pubmed: 9230594
J Clin Endocrinol Metab. 1990 Apr;70(4):1202-7
pubmed: 2318940
J Bone Miner Res. 2013 May;28(5):1007-13
pubmed: 23239264
Med Phys. 1994 Apr;21(4):503-8
pubmed: 8058015
J Bone Miner Res. 1989 Apr;4(2):137-41
pubmed: 2658477
Calcif Tissue Int. 1996 Jun;58(6):409-14
pubmed: 8661481
Clin Gastroenterol Hepatol. 2013 Mar;11(3):278-85
pubmed: 23103821
Gastroenterology. 2011 Jan;140(1):116-23
pubmed: 20854819
J Bone Miner Res. 2001 Jan;16(1):97-103
pubmed: 11149495
J Crohns Colitis. 2020 Sep 16;14(9):1256-1263
pubmed: 32170313
Metabolism. 1983 Feb;32(2):151-6
pubmed: 6298567
Osteoporos Int. 2013 Nov;24(11):2837-46
pubmed: 23681084
Cartilage. 2019 Nov 24;:1947603519888793
pubmed: 31762295
Osteoporos Int. 1998;8(6):618-25
pubmed: 10326070
IEEE Trans Med Imaging. 1986;5(3):152-61
pubmed: 18244001
J Bone Miner Res. 2001 Apr;16(4):697-704
pubmed: 11315997
J Crohns Colitis. 2016 May;10(5):532-40
pubmed: 26818661
J Clin Endocrinol Metab. 1981 Jan;52(1):111-5
pubmed: 6969728
Eur J Gastroenterol Hepatol. 2018 Jan;30(1):101-106
pubmed: 29064848
Calcif Tissue Int. 1992 Jun;50(6):507-10
pubmed: 1525705
Eur J Clin Invest. 2004 Feb;34(2):137-42
pubmed: 14764077
Skeletal Radiol. 2019 Jul;48(7):1023-1032
pubmed: 30506302
Osteoporos Int. 2016 Jan;27(1):39-48
pubmed: 26252975
Gastroenterology. 2003 Dec;125(6):1591-7
pubmed: 14724810
J Cell Biochem. 2008 Jan 1;103(1):335-45
pubmed: 17516544